As US funding falters, mRNA cancer vaccine pioneers face new hurdles
As the Trump administration distances itself from mRNA technology, promising cancer vaccines could suffer.
Big pharma companies hit with FDA warning letters in drug ad clampdown
GSK plans $30bn investment for R&D in US
Eli Lilly picks Virginia for $5bn drug manufacturing plant
Reunion Neuroscience expands Series A to $133m after positive trial milestones
VarmX and CSL form alliance for blood coagulation treatment development
Analysis
View More
Themes
View MoreTrump blames Covid-19 drugmakers for fuelling CDC turmoil
Trump has asked pharma companies to justify efficacy for their Covid-19 drugs as he attempts to quell unrest in his administration.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Oxford University and Ellison Institute link for AI vaccine research
FDA approves mRNA vaccines for new Covid-19 season amid political tension
AI psychosis sees users ‘co-creating delusions with technology’ – expert
Opadry complete film coating system: 45 years of trust, innovation and performance